This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mindray To Participate In Upcoming Investor Conferences And Events

SHENZHEN, China, Dec 31, 2012 /PRNewswire-FirstCall/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present in four upcoming investor conferences and events.

Ms. May Li, Mindray's Deputy Chief Financial Officer, and Ms. Cathy Gao, Mindray's Investor Relations Manager, will attend the 31st Annual J.P. Morgan Healthcare Conference to be held January 7-11, 2013 at the Westin St. Francis Hotel in San Francisco. Ms. Li will present at 11:00 am PST on Wednesday, January 9, and will meet with investors from January 7 to January 9.

On January 7, Ms. Li and Ms. Gao will also participate in the 2nd Annual China Healthcare Dinner with C-Level Executives co-hosted by Elsevier Business Intelligence, KPCB China, Oppenheimer & Co. and Western Bridge in San Francisco. 

Next will be the UBS Greater China Conference 2013, to be held January 14-16 at the Pudong Shangri-La Hotel in Shanghai. Mindray's President and CEO, Mr. Li Xiting, and Ms. May Li will attend the conference on January 14.

Mr. Li and Ms. May Li will also participate in the 11th Annual DB Access China Conference to be held January 14-15, 2013 at the Grand Hyatt Hotel in Beijing. Mr. Li and Ms. May Li will present at 9:00 am HKT on Tuesday, January 15, and will meet with investors on the same day.

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.

For investor and media inquiries, please contact:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs